Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,9367,96-0,73
Msft429,64429,738,70
Nokia4,3854,451,06
IBM239,12239,31-1,08
Mercedes-Benz Group AG52,6252,65-2,73
PFE24,0424,05-1,50
01.05.2025 19:55:51
Indexy online
AD Index online
select
AD Index online
 

  • 01.05.2025 16:59:59
William Demant Hldg (Copenhagen)
Poslední obchod Změna (%) Změna (DKK) Objem obchodů (DKK)
236,60 -0,76 -1,80 53 508 996
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 01.05.2025
Popis společnosti
Obecné informace
Název společnostiDemant A/S
TickerDEMANT
Kmenové akcie:Ordinary Shares
RICDEMANT.CO
ISINDK0060738599
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 21 349
Akcie v oběhu k 08.04.2025 205 719 190
MěnaDKK
Kontaktní informace
UliceKongebakken 9
MěstoSMOERUM
PSČ2765
ZeměDenmark
Kontatní osobaPeter Pudselykke
Funkce kontaktní osobyHead - Investor Relations
Telefon4 539 177 300
Fax4539277900
Kontatní telefon4 539 177 300

Business Summary: Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Demant A/S revenues increased 4% to DKR22.42B. Net income before extraordinary items increased 3% to DKR2.89B. Revenues reflect Hearing Care segment increase of 9% to DKR9.93B, Europe segment increase of 7% to DKR9.3B, North America segment increase of 2% to DKR9.23B. Net income was partially offset by Labor & Related Expenses - Distribution increase of 10% to DKR6.3B (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007All Other Health & Personal Care Stores
NAICS2007All Oth Misc Ambulatory Health Care Services
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997All Other Health and Personal Care Stores
NAICS1997All Other Miscellaneous Ambulatory Health Care Services
SICSurgical Appliances And Supplies
SICElectromedical Equipment



  • Poslední aktualizace: 01.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Member of the Executive BoardSoeren Nielsen5401.04.201716.06.2015
Chief Financial Officer, Member of the Executive BoardRene Schneider5201.09.201501.09.2015
President - Diagnostics, Member of the Executive BoardAnne-karen Hunt4801.11.202401.11.2024
President - Hearing Care, Member of the Executive BoardNiels Wagner5401.04.2022